- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
CORONA Remedies Limited — Important, 07-08-2026: Updates
07-08-2026 | 03:53 pm
07-08-2026 | 03:53 pm
CORONA Remedies board met and approved Q1 financial results. Revenue grew 21.9% YoY to ₹422.4 Cr, PAT up 30.1% YoY to ₹60.1 Cr. The company inaugurated an EU-GMP approved Female Hormone Facility and integrated the Wokadine brand.
No comments yet. Be the first to comment!